INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Open-market saleVerified data

Magrath George sold IRD

Director, Chief Executive Officer · Opus Genetics, Inc. · Common Stock

Side
SELL
Value
$110K
Shares
28.3K
Price
$3.9
Executed
Nov 3, 2026
Disclosed
Nov 5, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 3 executedNov 5, 2026 disclosed

IRD · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
24/ 100 · ROUTINE
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+4 / 25

    $110K reported value · 1.4% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · IRD

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    30
    FF
    Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks
    IRDOpus Genetics, Inc.
    Open-market sale
    		SELL$2.76M
    556.0K sh
    		Sep 30, 2026Oct 2, 2026
    traded Sep 30, 2026
    		+2dSEC FORM 4

    Evidence

    34
    FF
    Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks
    IRDOpus Genetics, Inc.
    Open-market sale
    		SELL$7.39M
    1.70M sh
    		May 18, 2026May 20, 2026
    traded May 18, 2026
    		+2dSEC FORM 4

    Evidence

    38
    FF
    Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks
    IRDOpus Genetics, Inc.
    Open-market sale
    		SELL$8.60M
    4.00M sh
    		Dec 9, 2025Dec 11, 2025
    traded Dec 9, 2025
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001140361-26-042102
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Nov 3, 2026
    Published
    Nov 5, 2026
    Ingested by INSIDER
    Nov 5, 21:23 UTC
    Last re-read
    Nov 5, 21:23 UTC

    Extracted facts

    Filer
    Magrath George
    Role
    Director, Chief Executive Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    Opus Genetics, Inc.
    Ticker
    IRD
    Shares
    28.3K
    Price per share
    $3.9
    Value
    $110,184
    Execution date (reported)
    Nov 3, 2026
    Owned after transaction
    2.01M shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 28.3K
    • Price: $3.8992

    = $110,184

    What this establishes

    Magrath George filed this Form 4 reporting a open-market sale of IRD on Nov 3, 2026. It became public on Nov 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, Chief Executive Officer
    Magrath Georgecik:0001999390
    Issuer
    Opus Genetics, Inc.cik:0001228627

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.